This article provides a summary of the weight reduction effectiveness, glycemic control, and safety of semaglutide (up to a 2.4-mg dose) and tirzepatide (up to a 15-mg dose), with a focus on the Semaglutide Treatment Effect in People with Obesity (STEP) 2, SURPASS-1, and SURPASS-2 trials, which involved patients with type 2 diabetes mellitus
Some insurers use step therapy
When we introduce Semaglutide, we are essentially amplifying this signal
These devices are convenient and potentially economical, but there have been questions about long-term in-use stability, particularly if the medicine remains inside a cartridge for prolonged periods under varying storage conditions
36.Schuemie MJ, Cepeda MS, Suchard MA, et al
By promoting satiety and reducing appetite, GLP-1 may aid in weight management efforts